1. Halozyme Therapeutics Inc.
  2. Halozyme Therapeutics Inc. Ownership

Historical shareholding details of Fuller & Thaler Asset Management Inc holdings in Halozyme Therapeutics Inc. (HALO)

Monthly changes of Fuller & Thaler Asset Management Inc shareholding in Halozyme Therapeutics Inc. over the previous months

Month Name Total no. shares held Percent Holding
Feb 28, 2025 Fuller & Thaler Asset Management Inc 779,940 0.63%
Jan 31, 2025 Fuller & Thaler Asset Management Inc 696,640 0.57%
Dec 31, 2024 Fuller & Thaler Asset Management Inc 887,852 0.72%
Dec 31, 2024 Fuller & Thaler Asset Management Inc 671,340 0.53%
Nov 30, 2024 Fuller & Thaler Asset Management Inc 661,890 0.52%
Oct 31, 2024 Fuller & Thaler Asset Management Inc 649,290 0.51%
Sep 30, 2024 Fuller & Thaler Asset Management Inc 823,544 0.65%
Sep 30, 2024 Fuller & Thaler Asset Management Inc 606,870 0.48%
Aug 31, 2024 Fuller & Thaler Asset Management Inc 586,110 0.46%
Jul 31, 2024 Fuller & Thaler Asset Management Inc 568,310 0.45%
Jun 30, 2024 Fuller & Thaler Asset Management Inc 716,573 0.56%
Jun 30, 2024 Fuller & Thaler Asset Management Inc 516,380 0.41%
May 31, 2024 Fuller & Thaler Asset Management Inc 468,880 0.37%
Apr 30, 2024 Fuller & Thaler Asset Management Inc 373,480 0.29%
Mar 31, 2024 Fuller & Thaler Asset Management Inc 568,361 0.45%
Mar 31, 2024 Fuller & Thaler Asset Management Inc 373,480 0.29%
Feb 29, 2024 Fuller & Thaler Asset Management Inc 339,395 0.27%
Jan 31, 2024 Fuller & Thaler Asset Management Inc 329,095 0.25%
Dec 31, 2023 Fuller & Thaler Asset Management Inc 409,682 0.32%
Dec 31, 2023 Fuller & Thaler Asset Management Inc 323,485 0.24%
Nov 30, 2023 Fuller & Thaler Asset Management Inc 290,285 0.22%
Oct 31, 2023 Fuller & Thaler Asset Management Inc 290,785 0.22%
Sep 30, 2023 Fuller & Thaler Asset Management Inc 368,394 0.28%
Sep 30, 2023 Fuller & Thaler Asset Management Inc 275,805 0.21%
Aug 31, 2023 Fuller & Thaler Asset Management Inc 275,805 0.21%
Jul 31, 2023 Fuller & Thaler Asset Management Inc 257,505 0.20%
Jun 30, 2023 Fuller & Thaler Asset Management Inc 338,002 0.26%
May 31, 2023 Fuller & Thaler Asset Management Inc 0 0.00%

View all ownership details of Halozyme Therapeutics Inc.